Overview

A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects

Status:
COMPLETED
Trial end date:
2025-07-13
Target enrollment:
Participant gender:
Summary
This is an open-label, single, ascending dose study evaluating the PK and safety of methylone in healthy subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Transcend Therapeutics
Treatments:
methylone